APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Skin Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transdermal Skin Patch Market Outlook and Growth Opportunities 2026

26 December 2025195 pages

Choose your research edition.

Industry ResearchTransdermal Skin Patch Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Skin Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transdermal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Skin Patch Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Skin Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transdermal Skin Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transdermal Skin Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transdermal Skin Patch market include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Skin Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Skin Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Skin Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Skin Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Skin Patch Segment by Company

Actavis

Changzhou Siyao

Henan Lingrui Pharmaceutical

Hisamitsu Pharmaceutical

Luye Pharma Group Ltd.

Mundipharma

Purdue Pharma L.P.

Rfl Pharmaceutical

Teikoku Pharma

Mylan

Novartis

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch

Fentanyl Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain

Stop Smoking Cigarettes

Treat an Overactive Bladder

Others

Transdermal Skin Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transdermal Skin Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transdermal Skin Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transdermal Skin Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Transdermal Skin Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Skin Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Skin Patch industry.

Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transdermal Skin Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transdermal Skin Patch Industry Trends Table 2. Transdermal Skin Patch Industry Drivers Table 3. Transdermal Skin Patch Industry Opportunities and Challenges Table 4. Transdermal Skin Patch Industry Restraints Table 5. Global Transdermal Skin Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transdermal Skin Patch Revenue Share by Company (2021-2026) Table 7. Global Transdermal Skin Patch Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Transdermal Skin Patch Sales Volume Share by Company (2021-2026) Table 9. Global Transdermal Skin Patch Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Transdermal Skin Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transdermal Skin Patch Key Company Manufacturing Base & Headquarters Table 12. Global Transdermal Skin Patch Company, Product Type & Application Table 13. Global Transdermal Skin Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Buprenorphine Transdermal Skin Patch Table 18. Significant Companies of Fentanyl Transdermal Skin Patch Table 19. Significant Companies of Clonidine Transdermal Skin Patch Table 20. Significant Companies of Nicotine Transdermal Skin Patch Table 21. Global Transdermal Skin Patch Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Transdermal Skin Patch Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Transdermal Skin Patch Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Transdermal Skin Patch Sales Volume Share by Type (2021-2026) Table 25. Global Transdermal Skin Patch Sales Volume Share by Type (2027-2032) Table 26. Global Transdermal Skin Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Transdermal Skin Patch Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Transdermal Skin Patch Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Transdermal Skin Patch Sales Value Share by Type (2021-2026) Table 30. Global Transdermal Skin Patch Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Relieve Severe Pain Table 32. Significant Companies of Stop Smoking Cigarettes Table 33. Significant Companies of Treat an Overactive Bladder Table 34. Significant Companies of Others Table 35. Global Transdermal Skin Patch Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Transdermal Skin Patch Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Transdermal Skin Patch Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Transdermal Skin Patch Sales Volume Share by Application (2021-2026) Table 39. Global Transdermal Skin Patch Sales Volume Share by Application (2027-2032) Table 40. Global Transdermal Skin Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Transdermal Skin Patch Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Transdermal Skin Patch Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Transdermal Skin Patch Sales Value Share by Application (2021-2026) Table 44. Global Transdermal Skin Patch Sales Value Share by Application (2027-2032) Table 45. Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Transdermal Skin Patch Sales by Region (2021-2026) & (W Units) Table 47. Global Transdermal Skin Patch Sales Market Share by Region (2021-2026) Table 48. Global Transdermal Skin Patch Sales by Region (2027-2032) & (W Units) Table 49. Global Transdermal Skin Patch Sales Market Share by Region (2027-2032) Table 50. Global Transdermal Skin Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Transdermal Skin Patch Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Transdermal Skin Patch Sales Value Share by Region (2021-2026) Table 53. Global Transdermal Skin Patch Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Transdermal Skin Patch Sales Value Share by Region (2027-2032) Table 55. Global Transdermal Skin Patch Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Transdermal Skin Patch Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Transdermal Skin Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 60. Global Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 61. Global Transdermal Skin Patch Sales by Country (2027-2032) & (W Units) Table 62. Global Transdermal Skin Patch Sales Market Share by Country (2027-2032) Table 63. Global Transdermal Skin Patch Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Transdermal Skin Patch Sales Value Market Share by Country (2021-2026) Table 65. Global Transdermal Skin Patch Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Transdermal Skin Patch Sales Value Market Share by Country (2027-2032) Table 67. Actavis Company Information Table 68. Actavis Business Overview Table 69. Actavis Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Actavis Transdermal Skin Patch Product Portfolio Table 71. Actavis Recent Development Table 72. Changzhou Siyao Company Information Table 73. Changzhou Siyao Business Overview Table 74. Changzhou Siyao Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Changzhou Siyao Transdermal Skin Patch Product Portfolio Table 76. Changzhou Siyao Recent Development Table 77. Henan Lingrui Pharmaceutical Company Information Table 78. Henan Lingrui Pharmaceutical Business Overview Table 79. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio Table 81. Henan Lingrui Pharmaceutical Recent Development Table 82. Hisamitsu Pharmaceutical Company Information Table 83. Hisamitsu Pharmaceutical Business Overview Table 84. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio Table 86. Hisamitsu Pharmaceutical Recent Development Table 87. Luye Pharma Group Ltd. Company Information Table 88. Luye Pharma Group Ltd. Business Overview Table 89. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio Table 91. Luye Pharma Group Ltd. Recent Development Table 92. Mundipharma Company Information Table 93. Mundipharma Business Overview Table 94. Mundipharma Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mundipharma Transdermal Skin Patch Product Portfolio Table 96. Mundipharma Recent Development Table 97. Purdue Pharma L.P. Company Information Table 98. Purdue Pharma L.P. Business Overview Table 99. Purdue Pharma L.P. Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio Table 101. Purdue Pharma L.P. Recent Development Table 102. Rfl Pharmaceutical Company Information Table 103. Rfl Pharmaceutical Business Overview Table 104. Rfl Pharmaceutical Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio Table 106. Rfl Pharmaceutical Recent Development Table 107. Teikoku Pharma Company Information Table 108. Teikoku Pharma Business Overview Table 109. Teikoku Pharma Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Teikoku Pharma Transdermal Skin Patch Product Portfolio Table 111. Teikoku Pharma Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mylan Transdermal Skin Patch Product Portfolio Table 116. Mylan Recent Development Table 117. Novartis Company Information Table 118. Novartis Business Overview Table 119. Novartis Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Novartis Transdermal Skin Patch Product Portfolio Table 121. Novartis Recent Development Table 122. Johnson & Johnson Company Information Table 123. Johnson & Johnson Business Overview Table 124. Johnson & Johnson Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Johnson & Johnson Transdermal Skin Patch Product Portfolio Table 126. Johnson & Johnson Recent Development Table 127. Teva Pharmaceutical Industries Ltd. Company Information Table 128. Teva Pharmaceutical Industries Ltd. Business Overview Table 129. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio Table 131. Teva Pharmaceutical Industries Ltd. Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Transdermal Skin Patch Distributors List Table 135. Transdermal Skin Patch Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Transdermal Skin Patch Product Image Figure 2. Global Transdermal Skin Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transdermal Skin Patch Sales (2021-2032) & (W Units) Figure 5. Global Transdermal Skin Patch Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Transdermal Skin Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Buprenorphine Transdermal Skin Patch Image Figure 10. Fentanyl Transdermal Skin Patch Image Figure 11. Clonidine Transdermal Skin Patch Image Figure 12. Nicotine Transdermal Skin Patch Image Figure 13. Global Transdermal Skin Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Transdermal Skin Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Transdermal Skin Patch Sales Volume Share by Type (2021-2032) Figure 16. Global Transdermal Skin Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Transdermal Skin Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Transdermal Skin Patch Sales Value Share by Type (2021-2032) Figure 19. Relieve Severe Pain Image Figure 20. Stop Smoking Cigarettes Image Figure 21. Treat an Overactive Bladder Image Figure 22. Others Image Figure 23. Global Transdermal Skin Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Transdermal Skin Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Transdermal Skin Patch Sales Volume Share by Application (2021-2032) Figure 26. Global Transdermal Skin Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Transdermal Skin Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Transdermal Skin Patch Sales Value Share by Application (2021-2032) Figure 29. Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Transdermal Skin Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Transdermal Skin Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Transdermal Skin Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 34. North America Transdermal Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Transdermal Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Transdermal Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 40. South America Transdermal Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Transdermal Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Transdermal Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Transdermal Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Transdermal Skin Patch Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Transdermal Skin Patch Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine Transdermal Skin Patch
  • Fentanyl Transdermal Skin Patch
  • Clonidine Transdermal Skin Patch
  • Nicotine Transdermal Skin Patch
Applications
  • Relieve Severe Pain
  • Stop Smoking Cigarettes
  • Treat an Overactive Bladder
  • Others
Companies covered
  • Actavis
  • Changzhou Siyao
  • Henan Lingrui Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Luye Pharma Group Ltd.
  • Mundipharma
  • Purdue Pharma L.P.
  • Rfl Pharmaceutical
  • Teikoku Pharma
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Skin Patch Sales Value (2021-2032)
  4. 1.2.2 Global Transdermal Skin Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Transdermal Skin Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transdermal Skin Patch Market Dynamics
  1. 2.1 Transdermal Skin Patch Industry Trends
  2. 2.2 Transdermal Skin Patch Industry Drivers
  3. 2.3 Transdermal Skin Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Skin Patch Industry Restraints
3 Transdermal Skin Patch Market by Company
  1. 3.1 Global Transdermal Skin Patch Company Revenue Ranking in 2025
  2. 3.2 Global Transdermal Skin Patch Revenue by Company (2021-2026)
  3. 3.3 Global Transdermal Skin Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Transdermal Skin Patch Average Price by Company (2021-2026)
  5. 3.5 Global Transdermal Skin Patch Company Ranking (2024-2026)
  6. 3.6 Global Transdermal Skin Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Transdermal Skin Patch Company Product Type and Application
  8. 3.8 Global Transdermal Skin Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transdermal Skin Patch Market by Type
  1. 4.1 Transdermal Skin Patch Type Introduction
  2. 4.1.1 Buprenorphine Transdermal Skin Patch
  3. 4.1.2 Fentanyl Transdermal Skin Patch
  4. 4.1.3 Clonidine Transdermal Skin Patch
  5. 4.1.4 Nicotine Transdermal Skin Patch
  6. 4.2 Global Transdermal Skin Patch Sales Volume by Type
  7. 4.2.1 Global Transdermal Skin Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Transdermal Skin Patch Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Transdermal Skin Patch Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Transdermal Skin Patch Sales Value by Type
  11. 4.3.1 Global Transdermal Skin Patch Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Transdermal Skin Patch Sales Value by Type (2021-2032)
  13. 4.3.3 Global Transdermal Skin Patch Sales Value Share by Type (2021-2032)
5 Transdermal Skin Patch Market by Application
  1. 5.1 Transdermal Skin Patch Application Introduction
  2. 5.1.1 Relieve Severe Pain
  3. 5.1.2 Stop Smoking Cigarettes
  4. 5.1.3 Treat an Overactive Bladder
  5. 5.1.4 Others
  6. 5.2 Global Transdermal Skin Patch Sales Volume by Application
  7. 5.2.1 Global Transdermal Skin Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Transdermal Skin Patch Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Transdermal Skin Patch Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Transdermal Skin Patch Sales Value by Application
  11. 5.3.1 Global Transdermal Skin Patch Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Transdermal Skin Patch Sales Value by Application (2021-2032)
  13. 5.3.3 Global Transdermal Skin Patch Sales Value Share by Application (2021-2032)
6 Transdermal Skin Patch Regional Sales and Value Analysis
  1. 6.1 Global Transdermal Skin Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Skin Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Skin Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Transdermal Skin Patch Sales by Region (2027-2032)
  5. 6.3 Global Transdermal Skin Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transdermal Skin Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transdermal Skin Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transdermal Skin Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Transdermal Skin Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transdermal Skin Patch Sales Value (2021-2032)
  12. 6.6.2 North America Transdermal Skin Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transdermal Skin Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Transdermal Skin Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transdermal Skin Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transdermal Skin Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transdermal Skin Patch Sales Value (2021-2032)
  21. 6.9.2 South America Transdermal Skin Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transdermal Skin Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transdermal Skin Patch Sales Value Share by Country, 2025 VS 2032
7 Transdermal Skin Patch Country-level Sales and Value Analysis
  1. 7.1 Global Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transdermal Skin Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transdermal Skin Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Transdermal Skin Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Transdermal Skin Patch Sales by Country (2027-2032)
  6. 7.4 Global Transdermal Skin Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transdermal Skin Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transdermal Skin Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transdermal Skin Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transdermal Skin Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transdermal Skin Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Transdermal Skin Patch Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Changzhou Siyao
  8. 8.2.1 Changzhou Siyao Company Information
  9. 8.2.2 Changzhou Siyao Business Overview
  10. 8.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
  12. 8.2.5 Changzhou Siyao Recent Developments
  13. 8.3 Henan Lingrui Pharmaceutical
  14. 8.3.1 Henan Lingrui Pharmaceutical Company Information
  15. 8.3.2 Henan Lingrui Pharmaceutical Business Overview
  16. 8.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
  18. 8.3.5 Henan Lingrui Pharmaceutical Recent Developments
  19. 8.4 Hisamitsu Pharmaceutical
  20. 8.4.1 Hisamitsu Pharmaceutical Company Information
  21. 8.4.2 Hisamitsu Pharmaceutical Business Overview
  22. 8.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
  24. 8.4.5 Hisamitsu Pharmaceutical Recent Developments
  25. 8.5 Luye Pharma Group Ltd.
  26. 8.5.1 Luye Pharma Group Ltd. Company Information
  27. 8.5.2 Luye Pharma Group Ltd. Business Overview
  28. 8.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
  30. 8.5.5 Luye Pharma Group Ltd. Recent Developments
  31. 8.6 Mundipharma
  32. 8.6.1 Mundipharma Company Information
  33. 8.6.2 Mundipharma Business Overview
  34. 8.6.3 Mundipharma Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
  36. 8.6.5 Mundipharma Recent Developments
  37. 8.7 Purdue Pharma L.P.
  38. 8.7.1 Purdue Pharma L.P. Company Information
  39. 8.7.2 Purdue Pharma L.P. Business Overview
  40. 8.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
  42. 8.7.5 Purdue Pharma L.P. Recent Developments
  43. 8.8 Rfl Pharmaceutical
  44. 8.8.1 Rfl Pharmaceutical Company Information
  45. 8.8.2 Rfl Pharmaceutical Business Overview
  46. 8.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
  48. 8.8.5 Rfl Pharmaceutical Recent Developments
  49. 8.9 Teikoku Pharma
  50. 8.9.1 Teikoku Pharma Company Information
  51. 8.9.2 Teikoku Pharma Business Overview
  52. 8.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
  54. 8.9.5 Teikoku Pharma Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Transdermal Skin Patch Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Transdermal Skin Patch Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Johnson & Johnson
  68. 8.12.1 Johnson & Johnson Company Information
  69. 8.12.2 Johnson & Johnson Business Overview
  70. 8.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
  72. 8.12.5 Johnson & Johnson Recent Developments
  73. 8.13 Teva Pharmaceutical Industries Ltd.
  74. 8.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  75. 8.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
  76. 8.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
  78. 8.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Skin Patch Value Chain Analysis
  2. 9.1.1 Transdermal Skin Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Skin Patch Sales Mode & Process
  6. 9.2 Transdermal Skin Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Skin Patch Distributors
  9. 9.2.3 Transdermal Skin Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst